Welcome to the BiosearchTech Blog
Be the first to hear about our new technologies, discover how our customers are using our products and enhance your research - all in our latest blog posts.

Choosing the best qPCR probe chemistry for your assay
There are many different chemistries available for qPCR probes offering scientists a wealth of options during assay development. However, the unique chemistry of each probe type means that you’ll get the best assay performance when you match the probe type to the application.
Read on to find out more about the chemistries in our industry-leading probe portfolio and what makes each of them shine.
Read moreThe BiosearchTech Blog
AMP conference 2022: Developing a 5-minute point-of-care PCR test
Posted on Wed, Jan 11, 2023 @ 08:15 AM
Topics: Molecular Diagnostics, SARS-CoV-2, Disease detection
Make your diagnostic workflows more adaptable
Posted on Mon, Jun 06, 2022 @ 02:47 PM
Topics: SARS-CoV-2, Nucleic acid extraction, Disease detection
Pandemic reflections: Adapting to a constant flux in testing priorities
Posted on Tue, Apr 05, 2022 @ 04:55 PM
Topics: SARS-CoV-2
Society can’t handle the caveats to each type of COVID-19 test
Posted on Fri, Feb 11, 2022 @ 04:58 PM
Topics: qPCR, SARS-CoV-2
Pandemic reflections: in the face of SARS-CoV-2 variants, COVID-19 testing remains essential
Posted on Tue, Jan 11, 2022 @ 12:00 PM
Topics: SARS-CoV-2
Pandemic reflections: unprecedented demand drives COVID-19 test developers to get creative
Posted on Tue, Dec 28, 2021 @ 09:30 AM
Topics: SARS-CoV-2
Technical bulletin: Omicron impact on SARS-CoV-2 mutation analysis and investigation
Posted on Thu, Dec 23, 2021 @ 11:45 AM
Topics: Molecular Diagnostics, SARS-CoV-2
Pandemic reflections: the world is short staffed
Posted on Tue, Dec 21, 2021 @ 06:52 PM
Topics: SARS-CoV-2
Ensuring our diagnostic assays detect the Omicron variant
Posted on Thu, Dec 09, 2021 @ 04:24 PM
Topics: Molecular Diagnostics, SARS-CoV-2
Streamlining diagnostic workflows for common respiratory diseases, such as SARS-CoV-2, influenza and RSV
Posted on Tue, Nov 30, 2021 @ 04:29 PM
Topics: Molecular Diagnostics, SARS-CoV-2, Disease detection
Technical bulletin: SARS-CoV-2 mutation analysis and investigation
Posted on Thu, Oct 14, 2021 @ 05:01 PM
Topics: Molecular Diagnostics, SARS-CoV-2
Can COVID-19 testing be made more sustainable during prolonged uncertainty?
Posted on Mon, Sep 27, 2021 @ 02:36 PM
Topics: Molecular Diagnostics, qPCR, SARS-CoV-2
Tips for early-stage MDx companies launching new tests during COVID-19 times
Posted on Thu, Sep 02, 2021 @ 02:00 PM
Topics: Molecular Diagnostics, SARS-CoV-2
Wastewater surveillance: a critical tool in pandemic management
Posted on Tue, Aug 31, 2021 @ 09:48 AM
Topics: SARS-CoV-2
Technical bulletin: Emerging SARS-CoV-2 mutations and their effect on the immune response
Posted on Wed, Aug 18, 2021 @ 03:45 PM
Topics: SARS-CoV-2
Genomic surveillance: 3 techniques to detect and characterise SARS-CoV-2 variants
Posted on Wed, May 19, 2021 @ 11:34 AM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing?
Posted on Tue, May 04, 2021 @ 11:03 AM
Topics: Molecular Diagnostics, SARS-CoV-2
Building resilience into SARS-CoV-2 testing workflows: considerations for choosing an RNA isolation method
Posted on Wed, Oct 21, 2020 @ 11:00 AM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
Pressing COVID-19 testing issues of today and the near future
Posted on Wed, Aug 26, 2020 @ 09:57 AM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
Sensitivity and accuracy in COVID-19 testing
Posted on Wed, Aug 19, 2020 @ 09:56 AM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
Scaling up COVID-19 viral testing
Posted on Wed, Aug 12, 2020 @ 09:47 AM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
Enabling a rapid response to COVID-19 by Honeywell and LGC, Biosearch Technologies
Posted on Wed, Jul 29, 2020 @ 02:40 PM
Topics: Molecular Diagnostics, Genomics, qPCR, SARS-CoV-2
Robust supply chains and open testing systems: How our AgBio roots meet the FDA's EUA process to enable solutions to the COVID-19 pandemic
Posted on Tue, May 19, 2020 @ 10:18 AM
Topics: Molecular Diagnostics, Genomics, qPCR, SARS-CoV-2
Behind the scenes: How our oligo synthesis team contributes to the reliability of your assays
Posted on Thu, Apr 30, 2020 @ 04:13 PM
Topics: Molecular Diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2
When you don’t need an EUA for SARS-CoV-2 testing
Posted on Fri, Apr 10, 2020 @ 05:00 PM
Topics: Molecular Diagnostics, SARS-CoV-2
Addressing COVID-19 together: LGC, Biosearch Technologies and Shanghai Liferiver Biotechnology Co., Ltd.
Posted on Tue, Mar 31, 2020 @ 12:13 PM
Topics: Molecular Diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2
What diagnostic test makers and CLIA labs in the US need to know about Emergency Use Authorization (EUA)
Posted on Tue, Mar 24, 2020 @ 01:58 PM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2
Coronavirus outbreak: Collaboration to meet the challenge
Posted on Mon, Mar 16, 2020 @ 02:30 PM
Topics: Molecular Diagnostics, Genomics, SARS-CoV-2